Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
genetic-analysis
Press Release
Jan 15, 2024
Hyris Fulfils Its Integration Into Ulisse Biomed to Give Birth to a New International Group Ready to Make Its Mark in the Global Biotech Market
Following the first official announcement at the beginning of December last year, Hyris completed the transfer of its shares into Ulisse Biomed via a reverse take-over transaction. The new group, strong of flawless interoperability between its leading technologies, aims to become a new benchmark of innovation in the national and international biotech market.
Read More
Press Release
Sep 27, 2023
Hyris Supports Researchers and Developers to Launch Testing Kits via New Onboarding Programs
Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to support both researchers and kit developers worldwide. New onboarding programs enable emerging players to accelerate their go-to-market, as well as established manufacturers and diagnostic providers to integrate their portfolio with ease, maximizing their cost-per-value strategy.
Read More
Press Release
Sep 26, 2023
Rancho BioSciences Collaborates to Standardize UK Biobank Clinical Data for Improved Genetic Analysis
Read More
Press Release
Aug 5, 2022
Hyris' New T-Cell Test is Finally Available to EU Countries to Easily Map Patients' Cellular Immunity to SARS-CoV-2
After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris Systemâ„¢.
Read More
Press Release
Dec 15, 2021
Hyris Fully Embraces the Immunology Sector to Better Fight COVID-19 and Beyond, Presenting Its New, Disruptive T-Cell Test to the International Conference 'A-Wish'
Hyris is going to present its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunology Symposium in Health, which will address strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2. This new solution leverages the Hyris Systemâ„¢, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.
Read More
Press Release
Feb 12, 2020
Diagnomics Introduces HealthLytix Alzheimer's Disease Risk Assessments Through GenoMatch.Me Employee Benefits Program
Read More
Press Release
May 31, 2014
Wall Street's Augury: Sequenom Inc. (Nasdaq:SQNM)
Sequenom has completed the sale of its Bioscience business to Agena Bioscience
Read More
First
Prev
1
Next
Last